Mark Curtis | BioProcess International

BioProcess International is part of the Informa Connect Division of Informa PLC

Informa PLC|ABOUT US|INVESTOR RELATIONS|TALENT

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

BPI Events About Subscribe Contribute

Upstream

Recent in Upstream

See all

Croda Pharma Ask the Expert

Sponsored Content

Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch Consistency Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch Consistency

byBPI Contributor

Oct 29, 2024

1 Hr View

thumbnail

Gene Therapies

A Scale-Up/-Down Platform for Fast-Paced Upstream Process Development of rAAV-Based Gene Therapies A Scale-Up/-Down Platform for Fast-Paced Upstream Process Development of rAAV-Based Gene Therapies

byTereza Pavlištová, Maria João Alves Correiaand 5 more

Oct 17, 2024

Downstream

Recent in Downstream

See all

Nagase special report

Sponsored Content

Advanced Saccharide Solutions in Biopharmaceutical Development: Paving the Way for Product Stability and Environmental Sustainability Advanced Saccharide Solutions in Biopharmaceutical Development: Paving the Way for Product Stability and Environmental Sustainability

byYosuke Shimojo, Toshio Ariyasuand 1 more

Dec 9, 2024

Saint Gobain Life Sciences filtration

Sponsored Content

Filter Integrity Uncovered: Techniques and Best Practices Filter Integrity Uncovered: Techniques and Best Practices

byBPI Contributor

Dec 3, 2024

30 Min View

Manufacturing

Recent in Manufacturing

See all

Image shows an outsourcing sign

Deal-Making

Contract catch-up: The latest cross-modality CDMO deals Contract catch-up: The latest cross-modality CDMO deals

byDan Stanton

Jan 10, 2025

6 Min Read

ValGenesis Special Report

Sponsored Content

Integrating Digital Transformation and Quality by Design for Enhanced Pharmaceutical Development Integrating Digital Transformation and Quality by Design for Enhanced Pharmaceutical Development

byMargarida Ventura

Dec 12, 2024

Analytical

Recent in Analytical

See all

Assays eBook

Sponsored Content

eBook: Developing Assays — Considerations Across the Analytical Spectrum eBook: Developing Assays — Considerations Across the Analytical Spectrum

byCheryl Scott, Dana Ciprianoand 6 more

Dec 12, 2024

Samsung Biologics Ask the Expert webcast

Sponsored Content

Advanced CLD with S-CHOice®: Higher Productivity with Transposase Technology and Improved ADCC with S-AfuCHO™Advanced CLD with S-CHOice®: Higher Productivity with Transposase Technology and Improved ADCC with S-AfuCHO™

byBPI Contributor

Dec 12, 2024

15 Min View

Business

Recent in Business

See all

Scorpius BioManufacturing Ask the Expert webcast

Sponsored Content

An Innovative Funding Model for Biotech Companies An Innovative Funding Model for Biotech Companies

byBPI Contributor

Dec 10, 2024

7 Min View

Lonza Ask the Expert webcast

Sponsored Content

Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality

byBPI Contributor

Nov 21, 2024

30 Min View

Therapeutic Modalities

Recent in Therapeutic Modalities

See all

Cell Therapies Insider eBook

Sponsored Content

eBook: Advancing Autologous Cell Therapies — Collaboration is Key eBook: Advancing Autologous Cell Therapies — Collaboration is Key

byJason Bock

Nov 21, 2024

Thermo Fisher supplier side

Sponsored Content

Address Challenges of Bispecifics and Antibody Fragments with Novel Affinity Resins Address Challenges of Bispecifics and Antibody Fragments with Novel Affinity Resins

byChiu Lau-Barre

Nov 15, 2024

BioProcess Insider

Recent in BioProcess Insider

See all

thumbnail

Therapeutic Class

Thermo cites Catalent, capacity, and Trumpian tariffs in positive CDMO outlook Thermo cites Catalent, capacity, and Trumpian tariffs in positive CDMO outlook

byShreeyashi Ojha

Jan 20, 2025

2 Min Read

A US flag juxtaposed with a symbolic representation of the department of commerce

Regulations

Department of Commerce cracks down on biotechnology exports Department of Commerce cracks down on biotechnology exports

byJosh Abbott

Jan 17, 2025

2 Min Read

Home
Mark Curtis

Mark Curtis

Latest from Mark Curtis

Planning for Commercial Scale of Cell Therapy and Regenerative Medicine Products, Part 2: Clinical Efficacy, Reimbursement, and Needle-to-Needle

Cell Therapies

Planning for Commercial Scale of Cell Therapy and Regenerative Medicine Products, Part 2: Clinical Efficacy, Reimbursement, and Needle-to-Needle Logistics Planning for Commercial Scale of Cell Therapy and Regenerative Medicine Products, Part 2: Clinical Efficacy, Reimbursement, and Needle-to-Needle Logistics

byRichard Grant, Mark Curtisand 1 more

Oct 15, 2015

Webinars

Ask the Expert webcasts

ATE Webcasts

Register Now: Big Impact from Small Samples: Harnessing High-Precision Tunable Laser Spectroscopy for Complex Bioprocessing Analysis

Ask the Expert webcasts

ATE Webcasts

Sponsored Content

Special Report

From Pipettes to Infusion Pumps: Volume Accuracy in Regulated Industries and Its Critical Impact

Read Now

Insider News

Iconovo taps Lonza for spray-dried obesity biologic
Jan 20, 2025
|
1 Min Read
Thermo cites Catalent, capacity, and Trumpian tariffs in positive CDMO outlook
Jan 20, 2025
|
2 Min Read
Department of Commerce cracks down on biotechnology exports
Jan 17, 2025
|
2 Min Read
Gilead cites manufacturing efficiencies as CAR-T advantage in 2025
Jan 17, 2025
|
2 Min Read

See all

Exosomes Europe

Jun 5 - Jun 6, 2024

Exploit Advances in Exosomes to Improve Efficiencies in Drug Delivery: Connect with senior-level executives and scientists who will share new data and novel case studies on advancing EV products through clinical stage towards commercialization

Learn More